ArticlePersonalized medicine2019

Clinical outcomes in men with prostate cancer who selected active surveillance using a clinical cell cycle risk score.

Sanjeev Kaul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.